Use of Nintedanib and Pirfenidone in Non-Idiopathic Pulmonary Fibrosis Lung Disease
Am J Respir Crit Care Med
.
2021 Jul 1;204(1):92-94.
doi: 10.1164/rccm.202012-4356RR.
Authors
Krishnan Warrior
1
,
Paul A Chung
1
,
Michal Reid
1
,
Bradford C Bemiss
1
Affiliation
1
Division of Pulmonary and Critical Care, Loyola University Medical Center, Maywood, Illinois.
PMID:
33951400
DOI:
10.1164/rccm.202012-4356RR
No abstract available
Publication types
Comment
MeSH terms
Humans
Indoles / therapeutic use
Lung Diseases*
Pyridones* / therapeutic use
Substances
Indoles
Pyridones
pirfenidone
nintedanib